A cross-sectional latent class analysis of self-reported snus use in men's and women's professional football in England
Year: 2025
Type: article
Study design: Observational Study
Abstract: OBJECTIVES: Anecdotally, snus is widely used in Europe by professional footballers. However, prevalence and motivations for use have not been determined, alongside a lack of robust data regarding its use on player health and performance. The aims of the current research were to assess snus use amongst professional football players and categorise users through latent class analysis (LCA). DESIGN: Mixed-method design involving a cross-sectional survey study of 628 male and 51 female professional footballers in England, and 16 semi-structured interviews with multidisciplinary football staff conducted during the 2023-24 season. METHODS: The survey included self-reported questions concerning prevalence, motivations, sources, and perceived effects. Data were analysed using descriptive statistics and LCA to categorise players through their behaviours. Interview questions addressed perceived prevalence and behaviours, performance and health impacts, and support required. Interview data was analysed using mixed coding to contextualise quantitative analysis. RESULTS: Overall, 18 % and 22 % of male and female footballers reported using snus, rising to 42 % and 39 % respectively for lifetime use. Snus use was initiated and motivated by a mix of factors including socialisation, boredom, relaxation, cravings, and stress management. Players were separated into three classes: occasional, daily, and habitual users demonstrating distinct profiles. CONCLUSIONS: Snus use appears commonplace in both men's and women's professional football, motivated by a complex set of personal and social factors. The identified types of snus users can inform personalised approaches to education and cessation interventions.
Authors: Daniel Read, Ed Cope, Michael Bennett, Lee Taylor
Institution: Loughborough University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,720
OpenAlex ID: W4410760952